Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The Cherenkov color image shows the possibility of improving the quality of radiation therapy.

2.

The Benefits of Exercise for Substance Use Disorders.

3.

PET-CT is better than contrast-enhanced CT as a predictor of survival in patients with metastatic breast cancer

4.

Glioblastoma treatment breakthrough shows promise

5.

NP-Led Outreach Ups Cancer Screening in Rural Women Veterans


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot